AU2010240642B2 - Novel use - Google Patents

Novel use Download PDF

Info

Publication number
AU2010240642B2
AU2010240642B2 AU2010240642A AU2010240642A AU2010240642B2 AU 2010240642 B2 AU2010240642 B2 AU 2010240642B2 AU 2010240642 A AU2010240642 A AU 2010240642A AU 2010240642 A AU2010240642 A AU 2010240642A AU 2010240642 B2 AU2010240642 B2 AU 2010240642B2
Authority
AU
Australia
Prior art keywords
gal
galactooligosaccharide
glc
cells
gos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2010240642A
Other languages
English (en)
Other versions
AU2010240642A1 (en
Inventor
Francesco Attanasio
Georgios Tzortzis
Jelena Vulevic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clasado Ltd
Original Assignee
Clasado Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40774842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2010240642(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Clasado Ltd filed Critical Clasado Ltd
Publication of AU2010240642A1 publication Critical patent/AU2010240642A1/en
Application granted granted Critical
Publication of AU2010240642B2 publication Critical patent/AU2010240642B2/en
Assigned to CLASADO RESEARCH SERVICES LIMITED reassignment CLASADO RESEARCH SERVICES LIMITED Request for Assignment Assignors: CLASADO INC.
Assigned to CLASADO LIMITED reassignment CLASADO LIMITED Request for Assignment Assignors: CLASADO RESEARCH SERVICES LIMITED
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
AU2010240642A 2009-04-23 2010-04-23 Novel use Active AU2010240642B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0906983.2 2009-04-23
GBGB0906983.2A GB0906983D0 (en) 2009-04-23 2009-04-23 Novel use
GB0920784.6 2009-11-27
GBGB0920784.6A GB0920784D0 (en) 2009-04-23 2009-11-27 Novel use
PCT/GB2010/050659 WO2010122344A1 (en) 2009-04-23 2010-04-23 Novel use

Publications (2)

Publication Number Publication Date
AU2010240642A1 AU2010240642A1 (en) 2011-11-10
AU2010240642B2 true AU2010240642B2 (en) 2013-03-14

Family

ID=40774842

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010240642A Active AU2010240642B2 (en) 2009-04-23 2010-04-23 Novel use

Country Status (25)

Country Link
US (1) US20120058972A1 (enExample)
EP (1) EP2421541B1 (enExample)
JP (1) JP2012524770A (enExample)
KR (1) KR20110138416A (enExample)
CN (1) CN102427818A (enExample)
AU (1) AU2010240642B2 (enExample)
BR (1) BRPI1015091A2 (enExample)
CA (1) CA2759442C (enExample)
CY (1) CY1120597T1 (enExample)
DK (1) DK2421541T3 (enExample)
ES (1) ES2688786T3 (enExample)
GB (3) GB0906983D0 (enExample)
HU (1) HUE040451T2 (enExample)
IL (1) IL215855A0 (enExample)
MX (1) MX341308B (enExample)
MY (1) MY151104A (enExample)
NZ (1) NZ595969A (enExample)
PL (1) PL2421541T3 (enExample)
PT (1) PT2421541T (enExample)
RU (1) RU2530567C2 (enExample)
SG (1) SG175313A1 (enExample)
TR (1) TR201810868T4 (enExample)
UA (1) UA106491C2 (enExample)
WO (1) WO2010122344A1 (enExample)
ZA (1) ZA201107821B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2492559B (en) * 2011-07-05 2018-07-25 Clasado Inc Composition and method for preventing or reducing the risk of developing a syndrome
BR112014001472A2 (pt) 2011-07-22 2017-02-21 Abbott Lab galactooligossacarídeos para prevenir lesões e / ou promover a cicatrização do trato gastrointestinal
CN103716787B (zh) 2012-09-29 2020-06-23 北京三星通信技术研究有限公司 一种支持对家用基站进行验证的方法
CA2983236A1 (en) 2015-04-23 2016-10-27 Kaleido Biosciences, Inc. Glycan therapeutics and methods of treatment
CN107158011A (zh) * 2017-05-25 2017-09-15 浙江大学 低聚半乳糖在制备治疗肠道疾病的药物中的用途
BR112021022447A2 (pt) * 2019-05-15 2021-12-28 Nutricia Nv Métodos para aumentar a função da barreira intestinal e/ou para a prevenção e/ou o tratamento de ruptura da barreira intestinal, método para o tratamento, a prevenção e/ou o alívio de uma condição associado à exposição a toxinas, fórmula infantil, fórmula de seguimento ou fórmula para criança de primeira infância, trissacarídeos, composições nutricionais, uso do trissacarídeo e usos de uma composição nutricional
US20240277739A1 (en) * 2021-07-01 2024-08-22 N.V. Nutricia Nutritonal compositions for gut barrier function
KR102453998B1 (ko) * 2022-01-07 2022-10-14 (주)네오크레마 갈락토올리고당을 포함하는 염증성 장질환의 예방, 개선 또는 치료용 조성물
GB2619977A (en) * 2022-06-24 2023-12-27 Clasado Res Services Limited Compositions and uses thereof
GB2623336A (en) * 2022-10-12 2024-04-17 Clasado Res Services Limited Compositions and uses thereof
GB2623335A (en) * 2022-10-12 2024-04-17 Clasado Res Services Limited Compositions and uses thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004052121A1 (en) * 2002-12-12 2004-06-24 Novartis Ag Prebiotic compositions
WO2005003329A1 (en) * 2003-06-30 2005-01-13 Clasado Inc. Novel galactooligosaccharide composition and the preparation thereof
WO2010023422A1 (en) * 2008-05-30 2010-03-04 Clasado Inc. Use of prebiotic galacto-oligosaccharides in the treatment of intestinal inflammation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0315266D0 (en) * 2003-06-30 2003-08-06 Clasado Inc Novel galactooligosaccharide composition and the preparation thereof
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
EP1887017A1 (en) * 2006-08-09 2008-02-13 Friesland Brands B.V. Prebiotic carbohydrate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004052121A1 (en) * 2002-12-12 2004-06-24 Novartis Ag Prebiotic compositions
WO2005003329A1 (en) * 2003-06-30 2005-01-13 Clasado Inc. Novel galactooligosaccharide composition and the preparation thereof
WO2010023422A1 (en) * 2008-05-30 2010-03-04 Clasado Inc. Use of prebiotic galacto-oligosaccharides in the treatment of intestinal inflammation

Also Published As

Publication number Publication date
EP2421541A1 (en) 2012-02-29
HUE040451T2 (hu) 2019-03-28
GB2482817B (en) 2014-02-26
KR20110138416A (ko) 2011-12-27
RU2530567C2 (ru) 2014-10-10
NZ595969A (en) 2013-03-28
WO2010122344A1 (en) 2010-10-28
PT2421541T (pt) 2018-10-15
CY1120597T1 (el) 2019-12-11
CA2759442C (en) 2016-01-19
CA2759442A1 (en) 2010-10-28
SG175313A1 (en) 2011-11-28
GB201120030D0 (en) 2012-01-04
TR201810868T4 (tr) 2018-08-27
IL215855A0 (en) 2012-01-31
MY151104A (en) 2014-04-15
EP2421541B1 (en) 2018-07-11
ZA201107821B (en) 2012-07-25
AU2010240642A1 (en) 2011-11-10
PL2421541T3 (pl) 2018-11-30
CN102427818A (zh) 2012-04-25
GB0920784D0 (en) 2010-01-13
ES2688786T3 (es) 2018-11-06
GB2482817A (en) 2012-02-15
JP2012524770A (ja) 2012-10-18
MX341308B (es) 2016-08-12
DK2421541T3 (en) 2018-09-24
UA106491C2 (uk) 2014-09-10
BRPI1015091A2 (pt) 2016-04-26
GB0906983D0 (en) 2009-06-03
US20120058972A1 (en) 2012-03-08
RU2011147390A (ru) 2013-05-27
MX2011011159A (es) 2011-11-07

Similar Documents

Publication Publication Date Title
AU2010240642B2 (en) Novel use
CA2724766A1 (en) Use of prebiotic galacto-oligosaccharides in the treatment of intestinal inflammation
Nijman et al. Characterization and quantification of oligosaccharides in human milk and infant formula
Boulangé et al. Impact of the gut microbiota on inflammation, obesity, and metabolic disease
Hernot et al. In vitro fermentation profiles, gas production rates, and microbiota modulation as affected by certain fructans, galactooligosaccharides, and polydextrose
KR101783383B1 (ko) 알파-(1,2)-분지형 알파-(1,6) 올리고덱스트란을 제조하기 위한 조성물 및 방법
RU2469558C2 (ru) Применение пробиотиков и волокон при диарее
US20240309408A1 (en) Methods of Use of Oligosaccharide Compositions for Modulating Microbiota and their Metabolic Products, and as Therapeutics for Health Applications
AU2015262214A1 (en) Composition for treating or preventing metabolic disease, containing, as active ingredient, extracellular vesicles derived from Akkermansia muciniphila bacteria
CN102670662A (zh) 糖醛酸和益生菌
CN107771083A (zh) 聚糖治疗剂和治疗方法
CN107427528A (zh) 聚糖治疗剂和其相关方法
US20140303067A1 (en) Treatment of eosinophilic esophagitis
KR101494901B1 (ko) 분지쇄 말토덱스트린을 포함하는 장용 소염 및/또는 진통제조성물
Diez-Municio et al. Efficient synthesis and characterization of lactulosucrose by Leuconostoc mesenteroides B-512F dextransucrase
Ambrogi et al. Bifidobacterial β-galactosidase-mediated production of galacto-oligosaccharides: structural and preliminary functional assessments
EP4522124A2 (en) Methods for treating urogenital health conditions
Macfarlane et al. Food and the large intestine
CN101372679B (zh) 一种双歧双歧杆菌菌株及其使用方法
Ambrogi et al. Bifidobacterial ß-galactosidase-mediated production of galacto-oligosaccharides: structural and preliminary functional assessments
KR102000714B1 (ko) 전호 잎 유래 루테올린 7-o-(6″-말로닐글루코사이드)를 유효성분으로 포함하는 관절염 및 자가면역질환의 예방 또는 치료용 조성물
Spence et al. Digestive Disease Week 2020
KR20240053740A (ko) 인간 모유 올리고당 및 베타-글루칸이 포함된 장기능 개선용 조성물
Ambrogi et al. β-Galactosidase-Mediated Production of Galacto-Oligosaccharides: Structural and Preliminary Functional Assessments
Garleb et al. Application of fructooligosaccharides to medical foods as a fermentable dietary fiber

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: CLASADO RESEARCH SERVICES LIMITED

Free format text: FORMER OWNER(S): CLASADO INC.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired
NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO PAY A RENEWAL FEE HAS BEEN EXTENDED TO 23 DEC 2021

PC Assignment registered

Owner name: CLASADO LIMITED

Free format text: FORMER OWNER(S): CLASADO RESEARCH SERVICES LIMITED